MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 04-22-2025
Danaher Corporation Operating Cash Flow 2011-2025 | DHR
Annual Operating Cash Flow Danaher Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.69 B | 7.16 B | 8.52 B | 8.36 B | 6.21 B | 3.95 B | 4.02 B | 3.48 B | 3.52 B | 3.8 B | 3.76 B | 3.59 B | 3.42 B | 2.63 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.52 B | 2.63 B | 4.94 B |
Quarterly Operating Cash Flow Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.3 B | - | 1.74 B | - | - | - | 1.97 B | - | - | 3.99 B | 1.87 B | - | 3.99 B | 2.26 B | 819 M | - | 2.84 B | 1.87 B | 703 M | - | 2.78 B | 1.86 B | 829 M | - | 2.64 B | 1.57 B | 560 M | - | 2.87 B | 2.05 B | 773 M | - | 2.57 B | 1.62 B | 524 M | - | 2.52 B | 1.5 B | 511 M | - | 2.51 B | 1.54 B | 636 M | - | 2.62 B | 1.65 B | 645 M | - | 1.8 B | 1.1 B | 436 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.99 B | 436 M | 1.76 B |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
884 K | $ 19.06 | -1.6 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 20.31 | -5.8 % | $ 221 M |  China |
 |
Co-Diagnostics
CODX
|
-22.1 M | $ 0.23 | -4.17 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 39.2 | -0.49 % | $ 1.09 B | USA |
 |
DarioHealth Corp.
DRIO
|
-30.4 M | $ 10.36 | 3.19 % | $ 294 M | Israel |
 |
BioNano Genomics
BNGO
|
-68.9 M | $ 1.51 | -0.9 % | $ 1.92 M | USA |
 |
Exact Sciences Corporation
EXAS
|
211 M | $ 101.86 | 0.28 % | $ 18.9 B | USA |
 |
DexCom
DXCM
|
748 M | $ 67.65 | 0.12 % | $ 26.1 B | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 26.63 | -0.34 % | $ 805 M | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-18.4 M | $ 19.19 | -1.49 % | $ 1.03 B | USA |
 |
Celcuity
CELC
|
-83.5 M | $ 101.0 | -1.22 % | $ 3.98 B | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
-7.34 M | $ 3.19 | -0.31 % | $ 102 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
2.72 B | $ 227.26 | 0.15 % | $ 41.2 B | USA |
 |
Guardant Health
GH
|
-240 M | $ 100.93 | -1.99 % | $ 12.4 B | USA |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
-8.7 M | $ 6.32 | -2.55 % | $ 573 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-7.4 M | $ 4.75 | -4.81 % | $ 2.55 M | USA |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 7.2 | 0.98 % | $ 1.56 B | USA |
 |
National Research Corporation
NRC
|
38.1 M | $ 18.95 | 1.55 % | $ 465 M | USA |
 |
Illumina
ILMN
|
837 M | $ 134.56 | -0.29 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
735 M | $ 203.33 | -0.11 % | $ 10.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.33 B | $ 175.36 | -0.34 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
-48.6 M | $ 6.79 | -0.44 % | $ 880 M | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
1.59 B | $ 252.95 | -0.4 % | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 182.75 | -0.05 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
929 M | $ 685.99 | -0.36 % | $ 56.6 B | USA |
 |
Lantheus Holdings
LNTH
|
545 M | $ 67.0 | 0.43 % | $ 4.64 B | USA |
 |
Personalis
PSNL
|
-45.2 M | $ 8.01 | -1.6 % | $ 475 M | USA |
 |
Mettler-Toledo International
MTD
|
968 M | $ 1 419.41 | -0.06 % | $ 30.1 B |  Schweiz |
 |
Agilent Technologies
A
|
1.48 B | $ 138.09 | -0.22 % | $ 42 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.6 | -3.7 % | $ 5.97 M | USA |